Eradivir, Inc.
- Biotech or pharma, therapeutic R&D
Eradivir is developing drugs that bind to diseased cells, serving as a beacon to guide the immune system.
June 16-19, 2025
Boston Convention & Exhibition Center
Eradivir is developing drugs that bind to diseased cells, serving as a beacon to guide the immune system.